ANIK (Anika Therapeutics, Inc.) Stock Financials & Earnings

ANIKAnika Therapeutics, Inc.

Mkt Cap$213M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$113M

Net Income (TTM)-$11M

EPS (TTM)-$0.76

Free Cash Flow (TTM)$4M

Gross Margin56.6%

Op. Margin-9.8%

Net Margin-9.6%

FCF Margin3.9%

P/S Ratio (TTM)1.9x

P/E Ratio (TTM)—

YoY Rev Growth+3.8%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$38M	$23M	-$13M
Q2 23	$44M	$29M	-$4M
Q3 23	$41M	$25M	-$8M
Q4 23	$43M	$26M	-$64M
Q1 24	$41M	$25M	-$5M
Q2 24	$31M	$20M	-$2M
Q3 24	$39M	$1M	-$28M
Q4 24	-$1M	$23M	$28M
Q1 25	$26M	$15M	-$4M
Q2 25	$28M	$14M	-$4M
Q3 25	$28M	$16M	-$3M
Q4 25	$31M	$19M	$646K

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Joint Preservation and Restoration	Non-Orthopedic	OA Pain Management
Q1 23	$13M	$2M	$23M
Q2 23	$13M	$2M	$29M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$80M	$0	$80M
Q2 23	$65M	$0	$65M
Q3 23	$71M	$0	$71M
Q4 23	$69M	$0	$69M
Q1 24	$69M	$0	$69M
Q2 24	$63M	$0	$63M
Q3 24	$62M	$0	$62M
Q4 24	$56M	$0	$56M
Q1 25	$53M	$0	$53M
Q2 25	$53M	$0	$53M
Q3 25	$58M	$0	$58M
Q4 25	$57M	$0	$57M

Shares Outstanding

Revenue Per Employee

Revenue / Employee